MS
Mitsuru Shomon
About Mitsuru Shomon
Data last updated:
Mitsuru Shomon is a Director at Eisai Pharmaceuticals India Private Limited (since 2021). The company operates in Pharma. Eisai Pharmaceuticals India Private Limited reported revenue of ₹402 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eisai Pharmaceuticals India Private Limited U21002AP2007PTC053247 | Director | 16 Sep 2021 | 2007 | ₹402 Cr (FY 2025) | Active |
Board colleagues of Mitsuru Shomon
| Name | DIN | Company | Designation |
|---|---|---|---|
| Akiko Nakahama | 11141964 | Eisai Pharmaceuticals India Private Limited | Director |
| Girish Dixit | 08591725 | Eisai Pharmaceuticals India Private Limited | Director |
| Kentaro Nagane | 10526897 | Eisai Pharmaceuticals India Private Limited | Director |
| Masahito Suzuki | 11142062 | Eisai Pharmaceuticals India Private Limited | Director |
| Shohei Kanazawa | 08760183 | Eisai Pharmaceuticals India Private Limited | Director |
| Takuya Kijima | 11343972 | Eisai Pharmaceuticals India Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mitsuru Shomon
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mitsuru Shomon
Mitsuru Shomon currently holds 1 directorship: Eisai Pharmaceuticals India Private Limited (Director, since 16 Sep 2021, revenue ₹402 Cr (FY 2025)).
Mitsuru Shomon was first appointed on 16 Sep 2021 as Director at Eisai Pharmaceuticals India Private Limited.
The current boards of Mitsuru Shomon's companies include Akiko Nakahama (Eisai Pharmaceuticals India Private Limited), Girish Dixit (Eisai Pharmaceuticals India Private Limited), Kentaro Nagane (Eisai Pharmaceuticals India Private Limited), Masahito Suzuki (Eisai Pharmaceuticals India Private Limited), Shohei Kanazawa (Eisai Pharmaceuticals India Private Limited), Takuya Kijima (Eisai Pharmaceuticals India Private Limited).